Stay updated on Insulin Glargine vs Lantus® in Type 1 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Insulin Glargine vs Lantus® in Type 1 Diabetes Clinical Trial page.

Latest updates to the Insulin Glargine vs Lantus® in Type 1 Diabetes Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedSite revision updated to v3.5.0 with v3.4.3 removed.SummaryDifference0.0%

- Check15 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3. This change updates the page version history.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedThe page now displays Revision: v3.4.2 and removes the earlier funding-status notice and Revision: v3.4.1. The core study details and navigation remain unchanged; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check50 days agoChange DetectedAdded a general funding notice with a v3.4.1 update. Removed the 'Type 1 diabetes' topic and related items (MedlinePlus Genetics) tied to the prior v3.4.0.SummaryDifference0.2%

- Check58 days agoChange DetectedUI updates include a 'Show glossary' option and new topic labels such as 'Type 1 diabetes' and related topics (e.g., MedlinePlus Genetics), along with metadata changes reflecting revision/version information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check72 days agoChange DetectedMinor metadata update: Revision v3.3.4 replaces v3.3.3; no impact on study data or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Insulin Glargine vs Lantus® in Type 1 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Insulin Glargine vs Lantus® in Type 1 Diabetes Clinical Trial page.